• OPEN AN ACCOUNT
Indian Indices
Sensex
72,529.07 -242.65
( -0.33%)
Global Indices
Nasdaq
51,510.98 -338.64
(-0.65%)
Dow Jones
7,705.40 -59.01
(-0.76%)
Hang Seng
65,155.57 -722.05
(-1.10%)
Nikkei 225
10,628.22 -56.66
(-0.53%)
Forex
USD-INR
95.79 -0.10
(-0.10%)
EUR-INR
109.09 0.01
(0.01%)
GBP-INR
126.83 0.01
(0.01%)
JPY-INR
0.61 0.00
(0.68%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
43.8
44118.03
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.8
 

Genesys International wins Rs 283-cr contract for Ahmedabad GIS 3D digital map platform
Sep 24,2026

Genesys International Corporation has been awarded one of India's largest Digital twin Spatial intelligence contracts, a Rs 283 crore World Bank-funded contract to develop a comprehensive Geographic Information System (GIS) 3D digital map platform of Ahmedabad, creating a unified digital foundation for urban planning, infrastructure management and civic service delivery.

This will be a continuation of the leading position Genesys is building in the Digital twin, HD mapping and Physical AI space.

The project will cover approximately 625 sq km of Ahmedabad and will digitally map the city's land parcels, properties, roads, water networks, sewerage systems, stormwater drainage infrastructure and other critical civic assets. As part of the initiative, around 25 lakh properties will be surveyed, geocoded and assigned unique digital identities, creating a comprehensive property-level spatial database for the city.